Valuation: 3-D Matrix, Ltd.

Market Cap 45.05B 283M 245M 229M 210M 395M 27.04B 401M 2.69B 1.06B 13.53B 1.06B 1.04B P/E 2025
-5x
P/E 2026 16.6x
Enterprise Value 42.82B 269M 233M 218M 199M 376M 25.7B 381M 2.56B 1B 12.86B 1.01B 990M EV / Sales 2025
2.2x
EV / Sales 2026 5.86x
Free-Float
92.59%
Yield 2025 *
-
Yield 2026 -
1 day+4.45%
1 week+5.39%
Current month+6.99%
1 month+0.28%
3 months-31.12%
6 months-30.43%
Current year-1.95%
1 week 333
Extreme 333
353
1 month 306
Extreme 306
374
Current year 306
Extreme 306
793
1 year 206
Extreme 206
793
3 years 97
Extreme 97
793
5 years 97
Extreme 97
793
10 years 97
Extreme 97
1,144
Manager TitleAgeSince
President 52 2016-02-29
Investor Relations Contact 59 -
Corporate Officer/Principal 50 2019-06-30
Director TitleAgeSince
Chairman 72 2004-05-18
Director/Board Member 52 2007-06-30
Director/Board Member 45 2021-06-30
Change 5-day change 1-year change 3-year change Capi.($)
+4.45%+5.39%+44.26%+130.07% 283M
-0.90%+3.34%+6.25%+16.19% 50.03B
+0.89%+13.44%+491.34%+594.30% 44.36B
+3.08%+14.42%+24.57%+81.39% 40.82B
+1.38%+3.70%+34.54%+9.11% 39.83B
+0.85%+10.32%+21.22%+47.64% 32.51B
+0.08%+5.00% - - 16.85B
+1.99%+5.08%+38.70%+125.08% 16.81B
-0.40%+1.45%+5.37%+21.22% 14.05B
+3.56%+19.98%+86.23%+27.29% 13.22B
Average +1.52%+286.09%+83.61%+116.92% 26.88B
Weighted average by Cap. +1.08%+295.08%+107.40%+139.75%

Financials

2025 2026
Net sales 6.93B 43.63M 37.77M 35.31M 32.27M 60.81M 4.16B 61.76M 414M 162M 2.08B 164M 160M 10.89B 68.5M 59.3M 55.43M 50.66M 95.47M 6.53B 96.96M 650M 255M 3.27B 257M 252M
Net income -2.5B -15.74M -13.62M -12.74M -11.64M -21.93M -1.5B -22.28M -149M -58.6M -751M -59.1M -57.81M 4.16B 26.15M 22.64M 21.16M 19.34M 36.44M 2.49B 37.01M 248M 97.35M 1.25B 98.18M 96.04M
Net Debt 1.36B 8.56M 7.41M 6.93M 6.33M 11.93M 816M 12.11M 81.21M 31.86M 408M 32.14M 31.43M -2.23B -14.03M -12.15M -11.36M -10.38M -19.56M -1.34B -19.86M -133M -52.25M -670M -52.69M -51.54M
Logo 3-D Matrix, Ltd.
3-D Matrix Ltd is a Japan-based company mainly engaged in medical products business. Its Medical Products Business consists of the development and sales of medical products. Based on self-assembling peptide technology, it conducts research and development of medical devices and pharmaceuticals in the surgical, tissue regeneration, and drug delivery system (DDS) fields. Major development pipelines include absorbable topical hemostatic agents, mucosal elevation agents, post-bleeding prevention agents, next-generation hemostatic agents, and adhesion prevention agents in the surgical field, wound healing agents and alveolar bone reconstruction agents in the tissue regeneration field, and DDS for nucleic acid drugs in the DDS field.
Employees
129
Date Price Change Volume
26-08-10 JP¥352.00 +4.45% 1,080,500
26-08-07 JP¥337.00 -2.60% 951,100
26-08-06 JP¥346.00 0.00% 1,012,500
26-08-05 JP¥346.00 +2.67% 1,418,000
26-08-04 JP¥337.00 +0.90% 1,012,600

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 7777 Stock